Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

2001 Articles Found

Eric S. Winer, MD
Insight Blog
10/3/2022

Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia: What to Know

  • Chronic Myelogenous - CML
  • Leukemias
  • Blood Cancer
Members of the team representing Dana-Farber’s Young-Onset Colorectal Cancer Center at the Boston Marathon® Jimmy Fund Walk presented by Hyundai
Insight Blog
9/30/2022

Team Beyond Colorectal Cancer Members Ensure Another Excellent Jimmy Fund Walk

  • Colon Cancer
  • Gastrointestinal Cancer
Insight Blog
9/30/2022

Study Shows How PARP Inhibitors Can Be Empowered in Breast Cancer

  • Research
  • Breast Cancer
Rebecca L. Porter, MD, PhD
Insight Blog
9/22/2022

Can Aspirin Prevent Ovarian Cancer?

  • Ovarian Cancer
  • Gynecologic Cancer
Bruce Spiegelman, PhD
Insight Blog
9/19/2022

Exercise Hormone Reduces Parkinson’s Disease-Associated Brain Degeneration and Symptoms in Animal Model

  • Research
Dan Lynch of Waterbury, Connecticut, is a competitive rower who continued rowing throughout treatment for mantle cell lymphoma.
Insight Blog
9/19/2022

Rower Back to Calm Waters After Lymphoma Treatment

  • Patient Stories, Adult
  • Lymphomas
Lianne Kraemer in Iceland, 2022.
Insight Blog
9/15/2022

Metastatic Breast Cancer Patient Finds Hope — And Passes It On

  • Patient Stories, Adult
  • Metastatic Breast Cancer
  • Breast Cancer
William Hahn, MD, Executive Vice President and Chief Operating Officer of Dana-Farber Cancer Institute, and Daphne Haas-Kogan, MD, chair of the Department of Radiology at Dana-Farber Brigham Cancer Center, awaiting President Biden’s speech on Cancer Moonshot.
Insight Blog
9/13/2022

In Boston, Biden Calls for Unity in Fight Against Cancer

Insight Blog
9/12/2022

By Blocking DNA Repair, Drug Combination Proves Lethal to Hard-to-Treat Tumor Cells

  • Research